ChemDiv Presents Focused and Targeted Screening Compound Libraries

 Breaking News
  • No posts were found

ChemDiv Presents Focused and Targeted Screening Compound Libraries

August 01
21:20 2022

ChemDiv, a fully Integrated target-to-clinic contract research organization (CRO) headquartered in San Diego, CA USA, is a recognized global leader in discovery chemistry with the industry’s largest, most diverse, and most pharmacologically-relevant commercial collection of individually crafted, lead-like,  medicine-like, small molecules and building blocks.

Over the past three decades in commercial medicine discovery, ChemDiv have developed a range of approaches to both chemical diversity and highly specialized (focused) compound selections. ChemDiv’s libraries have been extensively validated both in ChemDiv biological assays and in the laboratories of over 200 external partners including pharma, biotech, academia and screening centers in the U.S., Europe, and Japan.

Company ChemDiv offer a shelf-available set of over 1.6 M individual solid compounds.

Low molecular weight organic compound collection is updated quarterly toincorporate new therapeutic trends and insights into molecular, cell biology, availability of novel ligands, as well as to adhere to the  most recent  definitions of lead-like properties. ChemDiv provide specialized Screening Libraries and chemical libraries focused on chemical diversity-, soluble diversity-, blood-brain permeability, rigid topology (spiro-heterocycles and macrolide analogs), advanced Fsp3 character, medium- and large-size rings (macrocycles), and other criteria.

ChemDiv computational, structural biology, synthetic and medicinal chemistry teams follow current trends in modern structure-based discovery chemistry to add novel diverse and targeted compounds at the rate of 50,000 molecules per year.

ChemDiv is a recognized global leader in medicine discovery solutions. Over the past 29 years ChemDiv has delivered hundreds of leads, medicine candidates and new medicine in the area of CNS, oncology, virology, inflammation, cardiometabolic and immunology to pharma, biotech and academic partners around the globe.

Media Contact
Company Name: ChemDiv
Contact Person: Media Relations
Email: Send Email
Phone: +1 858-794-4860
Address:10320 Camino Santa Fe, Suite B
City: San Diego
State: CA 92121-3103
Country: United States